LLY stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
LECHLEITER JOHN C2023/04/10President and COO155390-766662023-04-100000059478000005947878724
-
Ricks David A2023/04/09SVP and Pres, Lilly Bio-Meds170728-408462023-04-0900000594780000059478129882
-
LECHLEITER JOHN C2023/04/08President and COO155390-766662023-04-080000059478000005947878724
-
Hedley Mary Lynne2023/04/07512023-04-070000059478000005947851
-
Hedley Mary Lynne2023/04/06512023-04-060000059478000005947851
-
Zakrowski Donald A2023/04/05Chief Accounting Officer46594-272002023-04-050000059478000005947819394
-
Hedley Mary Lynne2023/04/04512023-04-040000059478000005947851
-
Hedley Mary Lynne2023/04/03512023-04-030000059478000005947851
-
Ricks David A2023/04/02SVP and Pres, Lilly Bio-Meds170728-408462023-04-0200000594780000059478129882
-
Ricks David A2023/04/01SVP and Pres, Lilly Bio-Meds170728-408462023-04-0100000594780000059478129882
Related News

BlackRock (NYSE:BLK) Stock: A Resilient Investment at $747.91 With Promising Growth Ahead
TradingNEWS Archive
11.05.25

Can NASDAQ:BIDU Surge Above $200? How Will AI and Robotaxi Businesses Impact Baidu’s Future Price?
TradingNEWS Archive
10.05.25

Is NASDAQ: INTC Ready for a Strong Recovery in 2025?
TradingNEWS Archive
10.05.25

Shell’s Bold Move: Can a Potential BP Acquisition Propel NYSE:SHEL to New Heights Amid $60 Brent Prices?
TradingNEWS Archive
09.05.25